Norbert Gleicher, MD

VINE PHARMACY

DR. GLEICHER is Medical Director, The Center for Human Reproduction, New York, NY; President, Foundation for Reproductive medicine, New York, NY; and Visiting Professor, Dept. of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of

Articles

Q&A: Controversy: Gender selection via preimplantation genetic diagnosis: ethical pros and cons of the controversy

August 01, 2009

If choosing gender is okay before fertilization, why shouldn't it be with PGD after fertilization, is the thrust of the "pro" argument. The other side calls PGD gender discrimination.